Industries > Pharma > Translational Regenerative Medicine Market Forecast 2019-2029

Translational Regenerative Medicine Market Forecast 2019-2029

Stem Cell Therapies, Tissue Engineered Products, Gene Therapies

PUBLISHED: 07 February 2019
PAGES: 334
PRODUCT CODE: PHA0354

Clear
WOOCS 2.2.1
DOWNLOAD SAMPLE

The Global Translational Regenerative Medicine market is estimated to grow at a CAGR of 23.3% in the first half of the forecast period. Stem cell therapies accounted for the majority of the revenue in the market with an estimated market share of 57.7% in 2018.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new report you will find 334-page report and you will receive 119 tables and 106 figures – all unavailable elsewhere.

The 334-page report provides clear detailed insight into the Global Translational Regenerative Medicine market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand new report today you stay better informed and ready to act.

Report Scope

• Global Translational Regenerative Medicine market forecasts from 2019-2029

• Global Translational Regenerative Medicine submarket forecasts from 2019-2029 covering:
• Stem Cell Therapies
• Tissue Engineered Products
• Gene Therapies

This study discusses the late-state clinical trials and pipeline as well as market drivers and restraints of each submarket.

• Translational Regenerative Medicine regional and national market forecasts from 2019-2029, covering:
• North America: US, Canada
• Europe: Germany, France, UK, Italy, Spain, Rest of Europe
• Asia-Pacific: China, Japan, India, Rest of Asia-Pacific
• Latin America: Brazil, Mexico, Rest of Latin America
• Middle East & Africa: GCC Countries, South Africa, Rest of Middle East & Africa

Translational Regenerative Medicine Market Forecast 2019-2029

Each regional market is further segmented by sector.

• Forecasts from 2019-2029 of the selected leading products in the Global Translational Regenerative Medicine market:
• Osteocel Plus
• Trinity ELITE
• TEMCELL /Prochymal
• Apligraf
• Dermagraft
• Epifix
• ReCell
• Neovasculgen
• Glybera (alipogene tiparvovec)
• IMLYGIC (talimogene laherparepvec)

• Assessment of the leading companies in the Global Translational Regenerative Medicine market:
• Athersys, Inc.
• Avita Medical
• AxoGen, Inc.
• MEDIPOST Co., Ltd.
• NuVasive
• Astellas Pharma
• Organogenesis Holdings Inc.
• Osiris Therapeutics, Inc.
• Pharmicell Co., Ltd.
• Regenerys Ltd.
• Takeda Pharmaceutical Company Limited
• uniQure N.V. N.V.
• Vericel Corporation

• Information on current developments, current advancements and current key approvals in the field of translational regenerative medicine market.

SWOT and Porter’s Five Force analysis of the translational regenerative medicine market

Visiongain’s study is intended for anyone requiring commercial analyses for the Translational Regenerative Medicine Market and leading companies. You find data, trends and predictions.

Buy our report today Translational Regenerative Medicine Market Forecast 2019-2029: Stem Cell Therapies, Tissue Engineered Products, Gene Therapies.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for Translational Regenerative Medicine Market Forecast 2019-2029


Download sample pages

Complete the form below to download your free sample pages for Translational Regenerative Medicine Market Forecast 2019-2029


Latest Pharma news

“Global Vaccines Sales market set to grow to $75bn by 2024” says new Visiongain report

Progress in R&D in the therapeutic vaccine field will yield revolutionary results and answer unmet medical needs. This will also lead to more innovative approaches to vaccine development.

25 June 2019

READ

“Global Inflammatory Bowel Diseases (IBD) Drug Market is estimated to reach $8.6bn by 2024” says new Visiongain report

Revenue growth will be driven by rising incidence and prevalence owing to modern lifestyles and improved awareness and diagnosis.

21 June 2019

READ

“Top 25 Vaccines market set to grow to $41bn by 2024” says new Visiongain report

There is an increasing focus to identify diseases that currently do not have a vaccine.

20 June 2019

READ

“Global Ophthalmic Drugs market set to grow to $33bn by 2024” says new Visiongain report

The market for ophthalmic drugs is a growing one.

17 June 2019

READ

Categories

Category